The North America colonoscopes market is expected to reach US$ 719.03 million by 2028 from US$ 516.92 million in 2021; it is estimated to grow at a CAGR of 4.8% from 2021 to 2028.
A few factors such as the increasing prevalence of colorectal cancer, growing research activities to extend its applications in therapeutic areas, technological advancements in colonoscopy devices, and development of robotic colonoscopes drive the market growth in the region. However, the availability of alternative diagnostic tests for rectal diseases hampers the growth of the market.
Colorectal cancer is a malignant tumor that develops in the tissues of colon or rectum. Colon and rectal cancer are often grouped due to common features of both conditions. Colorectal cancer is the third most common cancer type (excluding skin cancer) diagnosed every year in the US. In 2021, 149,500 adults are estimated to be diagnosed with colorectal cancer in the country. The incidence of this cancer type has been rising in young people since the mid-1990s. Among men and women of age 30–39 in the US, colorectal cancer is estimated to be the fourth most diagnosed cancer. It is estimated to cause 52,980 deaths (28,520 men and 24,460 women) in 2021. Furthermore, it is the second leading cause of cancer death in the country, among men and women combined, while it stands as the third leading cause of cancer death when men and women are considered separately. Such a high prevalence makes it the second most frequently occurring cancer, after breast cancer, and the second leading cause of death, after lung cancer. In ideal situations, where the cancer is diagnosed in early stages, doctors can remove the tumor via surgical procedures. A colonoscopy is an important screening test for colorectal cancer, and it has become a part of routine cancer screening. The annual count of adults getting screened for cancer surged by 3.3 million in the US during 2014–2016, which is considered a prime factor associated with a 30% decrease in colon cancer mortality rate in people older than 50 in the past decade. In its updated screening guidelines released in 2018, the American Cancer Society quoted colonoscopies as the gold standard for detecting cancers and precancerous polyps in the colon. In addition, studies suggest that colonoscopy can help reduce colorectal cancer incidence by ~40% and mortality by ~50%, which indicates a promising future for the North America colonoscopy devices market growth. Also, to significantly reduce the adenoma “miss rate” of standard forward-viewing colonoscopy, manufacturers across globe are continuously striving to improve the current colonoscopy techniques, by exploring more advanced optics and wider-angle visualization tools along with a user-friendly, intuitive endoscopic platform interface. The introduction of such technologies is fuelling the colonoscope market growth.
In North America, the US was heavily impacted by the COVID-19 pandemic. Due to the spread of the novel coronavirus, many cities were closed, resulting in treatments and cancellationsof various surgeries. During the initial phase of the COVID-19 outbreak in 2019, healthcare systems in the US quickly adapted to reduce disease transmission and reserve hospital beds for the infected. Although elective and non-urgent procedures were initially required to be delayed, prolonged delays or cancellations could lead to other public health crises due to the rising incidence of preventable and chronic diseases. The COVID-19 pandemic has resulted in several changes in gastroenterological practice, both directly and in response to recommendations from professional societies. The technology platform and healthcare modeling data showed an initial 90% decrease in colonoscopies and biopsies year over year; an estimated 1.7 million missed colonoscopies. Also, it estimated that an additional 4,500 deaths could be due to colon cancer alone over the next decade due to COVID-19-related delays. As a result, the COVID-19 pandemic has had a negative impact on the colonoscopes market growth.

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA COLONOSCOPES MARKET SEGMENTATION
By Product Type
- Fiber Optic Colonoscopy Devices
- Video Colonoscopy Devices
By Application
- Colorectal Cancer
- Lynch Syndrome
- Ulcerative Colitis
- Crohn's Disease
- Polyp
By End User
- Hospitals
- Ambulatory Surgery Center
- Other End Users
By Country
- US
- Canada
- Mexico
Company Profiles
- Fujifilm Corporation
- Olympus Corporation
- KARL STORZ SE & Co. KG
- PENTAX Medical
- Boston Scientific Corporation
- Ambu A/S
- SonoScape Medical Corp.
North America Colonoscopes Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 516.92 Million |
Market Size by 2028 | US$ 719.03 Million |
Global CAGR (2021 - 2028) | 4.8% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- Fujifilm Corporation
- Olympus Corporation
- KARL STORZ SE & Co. KG
- PENTAX Medical
- Boston Scientific Corporation
- Ambu A/S
- SonoScape Medical Corp.


